YANTRIC INC FOR PROFIT CORPORATION

Their core work

Yantric is a US-based technology SME specializing in haptic feedback systems and virtual reality simulation for medical and laboratory applications, with a focused niche in cellular micromanipulation. Their work centers on building tools that make high-precision, operator-dependent procedures — specifically IVF embryo microinjection — more accessible, trainable, and eventually automatable. In HapticCell they contributed to a low-cost haptic system enabling autonomous microinjection; in CellTrainer they helped develop a real-time multi-physics VR simulator for training embryologists. Their value proposition is translating advanced robotics and simulation research into affordable clinical tools for assisted reproduction.

What they specialise in

How they've shifted over time

Both projects fall within a tight 2017–2019 window, so longitudinal evolution is limited, but a clear directional shift is visible within that span. HapticCell addressed the physical manipulation problem — hardware, force feedback, automation — while CellTrainer pivoted to the training and simulation problem, replacing physical practice with a software-based VR environment. This suggests Yantric is building a product suite around the full IVF microinjection workflow: first automate the task, then train the humans who perform it.

Yantric appears to be expanding from physical robotics instrumentation toward simulation and training software, which typically signals a move toward scalable, recurring-revenue product lines in the medtech training market.

How they like to work

Yantric has never acted as a project coordinator — in both EU projects they appear as a participant, likely serving as the commercial technology partner behind an ERC-funded researcher seeking to prove market viability. With only one unique consortium partner across both projects, their EU network is a single bilateral relationship rather than a broad consortium presence. This pattern is characteristic of an ERC spinout or closely allied commercial vehicle rather than an independently networked EU research actor.

Yantric has collaborated with a single partner in a single country across all EU activity — an unusually narrow footprint that reflects their role as a dedicated commercialization partner for one research group rather than a broad EU network participant. As a US company, their transatlantic involvement in ERC Proof of Concept grants is itself notable.

What sets them apart

Yantric occupies a rare position as a North American SME embedded in European ERC Proof of Concept commercialization — bringing US product development culture and potential market access into EU research translation. Their specific niche (haptics and VR for IVF microinjection) is narrow but commercially significant: this is a procedure performed millions of times annually worldwide, still heavily dependent on operator skill, with virtually no established simulation training tools on the market. For a consortium building a medtech or robotic surgery spinout, Yantric brings both the technical product layer and a bridge to the North American fertility clinic market.

Highlights from their portfolio

• HapticCell
  Targets full automation of a delicate manual clinical procedure (IVF microinjection) through haptic force-feedback — a commercially significant goal in a market where embryologist shortages are a documented global problem.
• CellTrainer
  Combines multi-physics real-time simulation with VR to create a training platform for a procedure that currently requires years of hands-on apprenticeship, with clear potential as a scalable medtech product.